Skip to main content
. 2024 Jan 9;16(2):287. doi: 10.3390/cancers16020287

Table 2.

Multivariable analyses.

Factor Hazard Ratio (95% CI) p-Value
RFS-Combined cohort
31-GEP
Class 1A Reference --
Class 1B/2A 2.63 (1.43–4.83) 0.002
Class 2B 5.16 (2.54–10.47) <0.001
AJCC
Stage IA Reference --
Stage IB 2.98 (1.64–5.40) <0.001
MSS-Combined cohort
31-GEP
Class 1A Reference --
Class 1B/2A 2.35 (0.60–9.29) 0.223
Class 2B 11.08 (3.10–39.63) <0.001
AJCC
Stage IA Reference --
Stage IB 3.00 (0.87–10.37) 0.082
MSS-SEER cohort
31-GEP
Class 1A Reference --
Class 1B/2A 1.37 (0.50–3.71) 0.542
Class 2B 9.23 (4.23–20.18) <0.001
AJCC
Stage IA Reference --
Stage IB 0.82 (0.39–1.74) 0.609